Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks

Trump's FDA nominee Heidi Overton could bring renewed scrutiny to mifepristone, says Americans United for Life CEO who calls her a "pro-life" pick.
Have a take on this story? Discuss it on Gab — no account needed to read, free to join to post.
Discuss on GabWant a second read? Ask Gab AI to analyze this story — private, no account needed to start.
Ask Gab AI💡 AI analysis provides alternative perspectives on current events